UBS Lifts Target on Abbott Labs (ABT) Ahead of Split
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $111.25 -0.02%
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
26 Buy, 9 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS boosted its price target on Buy-rated Abbott Labs (NYSE: ABT) from $72 to $74, ahead of the finalizing of the its split on 12/31 after which the company will trade as two stocks.
"For New ABT, we model 3-yr rev & EBITDA growth of 5% & 9% w/ AbbVie at 4% & 4%. Notably, we expect ABT to provide details on NEWCO cap structures & divs over next 1-2 months."
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Shares of Abbott Labs closed at $69.27 yesterday.
"For New ABT, we model 3-yr rev & EBITDA growth of 5% & 9% w/ AbbVie at 4% & 4%. Notably, we expect ABT to provide details on NEWCO cap structures & divs over next 1-2 months."
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Shares of Abbott Labs closed at $69.27 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades Abbott Labs (ABT) to Outperform
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
- New Street Research Upgrades Micron Technology (MU) to Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
